The dynamics of prediabetes market is expected to increase by the major drivers such as rising prevalent population, technological advancements, and upcoming therapies in the 7MM during the forecast period [2022–2032).
DelveInsight’s Prediabetes Market Insights report includes a comprehensive understanding of current treatment practices, prediabetes emerging drugs, market share of individual therapies, and current and forecasted market size from 2019 to 2032, segmented into 7MM (the United States, the EU5 (the United Kingdom, Italy, Spain, France, and Germany), and Japan.
Key Takeaways from the Prediabetes Market Report
- As per DelveInsight analysis, the prediabetes market is anticipated to witness growth at a considerable CAGR.
- Leading prediabetes companies such as Resverlogix Corporation, Boston Therapeutics, vTv Therapeutics, Valbiotis, BioTeSys, SynDevRx, Caelus Health, NanoPrecision Medical, and others are developing novel prediabetes drugs which can be available in the prediabetes market in the upcoming years.
- The prediabetes therapies in the pipeline include Apabetalone, BTI-320, Azeliragon, Totum-63, Pep2Dia, SDX-7320, Anaerostipes rhamnosivorans, OKV-119, and others.
- The total prediabetes market size will include the market size of the potential upcoming therapies and current treatment regimens in the seven major prediabetes markets.
Discover more about therapies set to grab major prediabetes market share @ Prediabetes Market Landscape
Prediabetes is a metabolic disorder that is thought to be a precursor to the development of type 2 diabetes. It is distinguished by elevated blood glucose levels that have not yet reached diabetes levels. Prediabetes is also known as impaired glucose tolerance or fasting glucose.
The exact prediabetes causes are not known, but family history and genetics appear to have a role. A lack of regular physical exercise and being overweight with extra fat appear to be significant causes. Prediabetics also do not adequately produce or utilize the hormone insulin, resulting in excess of glucose in circulation.
The prediabetes symptoms of increased thirst, increased urination, especially at night, tiredness, blurry vision, sores or cuts that would not heal, dark, thick, and often velvety patches on the skin (elbows, knees, neck, armpits, and knuckles), and others. There are several blood tests used for prediabetes diagnosis.
Prediabetes Epidemiology Segmentation
The prediabetes market report proffers epidemiological analysis for the study period 2019–2032 in the 7MM segmented into:
- Prevalent Population of Prediabetes
- Age-Specific Prevalent Cases of Prediabetes
- Gender-Specific Cases of Prediabetes
- Diagnosed and treatable Population of Prediabetes
Download the report to understand which factors are driving prediabetes epidemiology trends @ Prediabetes Epidemiological Insights
Prediabetes Treatment Market
Prediabetes is treatable, although preventing it is frequently simpler than treating it entirely. The major prediabetes causes are lifestyle variables, and adopting adjustments in some elements of life can greatly lower risk factors. Prediabetes nearly often develops before type 2 diabetes (T2D). Exercise and weight loss are the two most effective treatments for prediabetes because they can reduce insulin resistance and lower blood sugar levels.
Apart from adequate lifestyle management, prediabetic patients should consider many pharmacological therapies, such as a different method, improving insulin impact, and lowering Impaired Glucose Tolerance (IGT), which will finally halt the progression to T2D. The current prediabetes treatment paradigm includes the use of T2D-approved medicines such as Metformin, Thiazolidinediones, Glucagon-like peptide-1 analogs, DPP-IV inhibitors, and Alpha-glucosidase inhibitors.
To know more about prediabetes diet and treatment, visit @ Prediabetes Treatment Guidelines
Prediabetes Pipeline Therapies and Key Companies
- Totum-63: Valbiotis
- Pep2Dia: Ingredia
- Apabetalone: Resverlogix
- BTI-320: Boston Therapeutics
- Azeliragon: vTv Therapeutics
- SDX-7320: SynDevRx
Learn more about the prediabetic drugs in clinical trials @ Drugs for Prediabetes Treatment
The potential for developing therapeutics is the primary strength of the prediabetes market. As there is no recognized prediabetes treatment, new players have an opportunity to enter the prediabetes market. Moreover, the existing therapy choices are off-label medicines for treating people with prediabetes, which creates a platform for new medications to enter the prediabetes market. In addition, growth in research and development activities related to this indication may yield positive results in the prediabetes market in the future. Furthermore, the increasing disease prevalence and awareness will boost the prediabetes market during the forecast period.
However, some factors are impeding the growth of the prediabetes market. There is a lack of understanding about the ramifications of prediabetes, and many people are unaware that they have it. These are the primary barriers to the growth of the prediabetes market. In addition, the undiagnosed and unreported cases are also among the primary aspects that strive for the prediabetes market growth. Moreover, treatment with other diabetes medications is difficult. Prediabetes treatment focuses on symptom management and enhancing quality of life, as well as slowing or stopping the advancement of the disease. Since a change in lifestyle may control the disease, the need for medicines may be affected.
Scope of the Prediabetes Market Report
- Study Period: 2019–2032
- Coverage: 7MM [The United States, EU5 (Germany, France, Italy, Spain, and the United Kingdom), and Japan]
- Key Prediabetes Companies: Resverlogix Corporation, Boston Therapeutics, vTv Therapeutics, Valbiotis, BioTeSys, SynDevRx, Caelus Health, NanoPrecision Medical, and others
- Key Prediabetes Therapies: Apabetalone, BTI-320, Azeliragon, Totum-63, Pep2Dia, SDX-7320, Anaerostipes rhamnosivorans, OKV-119, and others
- Therapeutic Assessment: Prediabetes current marketed and emerging therapies
- Prediabetes Market Dynamics: Prediabetes market drivers and barriers
- Competitive Intelligence Analysis: SWOT analysis, PESTLE analysis, Porter’s five forces, BCG Matrix, Market entry strategies
- Unmet Needs, KOL’s views, Analyst’s views, Prediabetes Market Access and Reimbursement
Discover more about prediabetes drugs in development @ Prediabetes Clinical Trials
Table of Contents
|1.||Prediabetes Market Key Insights|
|2.||Prediabetes Market Report Introduction|
|3.||Prediabetes Market Overview at a Glance|
|4.||Prediabetes Market Executive Summary|
|5.||Disease Background and Overview|
|6.||Prediabetes Treatment and Management|
|7.||Prediabetes Epidemiology and Patient Population|
|9.||Prediabetes Emerging Drugs|
|10.||7 Major Prediabetes Market Analysis|
|11.||Prediabetes Market Outlook|
|12.||Potential of Current and Emerging Therapies|
|14.||Prediabetes Market Drivers|
|15.||Prediabetes Market Barriers|
Get in touch with our Business executive @ Healthcare Due Diligence Services
Prediabetes Epidemiology Forecast to 2032 report delivers an in-depth understanding of the disease, historical, and forecasted prediabetes epidemiology in the 7MM.
Prediabetes Pipeline Insight, 2022 report provides comprehensive insights about the pipeline landscape, pipeline drug profiles, including clinical and non-clinical stage products, and the key prediabetes companies, including BioTeSys, SynDevRx, Caelus Health, NanoPrecision Medical, among others.
Type 2 Diabetes Market Insights, Epidemiology, and Market Forecast-2032 report deliver an in-depth understanding of the disease, historical and forecasted epidemiology, as well as the market trends, market drivers, market barriers, and key type 2 diabetes companies, including Eli Lilly and Company, Sanofi, Novartis, Pfizer, among others.
Type 2 Diabetes Pipeline Insight, 2022 report provides comprehensive insights about the pipeline landscape, pipeline drug profiles, including clinical and non-clinical stage products, and the key type 2 diabetes companies, including Eli Lilly and Company, Sanofi, Novartis, Pfizer, among others.
Diabetes Pen Market Insights, Competitive Landscape, and Market Forecast-2027 report deliver an in-depth understanding of the disease, historical and forecasted epidemiology, as well as the market trends, market drivers, market barriers, and key type 2 diabetes companies, including BD, Medtronic, Terumo Group, F Hoffmann-La Roche Ltd., BIGFOOT BIOMEDICAL, INC, Eli Lilly, and Company, among others.
Diabetic Wound Market Insights, Competitive Landscape, and Market Forecast-2027 report deliver an in-depth understanding of the disease, historical and forecasted epidemiology, as well as the market trends, market drivers, market barriers, and key diabetic wound companies, including B Braun Meslungen AG, MEDCu, 3M, Integra LifeSciences., Organogenesis Inc, Bharat Biotech, RLS Global, among others.
Other Trending Reports
Persistent Depressive Disorder Market | Gene Therapy for Ocular Rare Disease Market | Congestive Heart Failure Market | CRISPR Therapies Pipeline | Desmoplastic Small Round Cell Tumors Market | India Healthcare Outlook Report | Psychosis Market | Dental Lasers Market | Primary Immune Deficiency Market I Dyslipidemia Market | Lateral Epicondylitis Disease Market | Castration-Resistant Prostate Cancer Market | Metrorrhagia Market | Global Messenger RNA-based Vaccines and Therapeutics Market | Negative Pressure Wound Therapy Systems Market | US Healthcare Outlook Report | Mucinous Cystic Neoplasms Market | Hot Flashes Market | Varicose Veins – Market | Hemostats Market | Injectable Drug Delivery Devices Market | Breast Pumps Market | Physiotherapy Equipment Market | Trastuzumab Biosimilars Insight | Deep Brain Stimulation Devices Market | Retinoblastoma Market | Venous Stenosis Market | Tumor Ablation Market | Substance Abuse Market | Insulin Glargine Biosimilar Insight | Interspinous Spacers Market | Anti-hypertension Market
Related Healthcare Blogs
DelveInsight is a leading Business Consultant, and Market Research firm focused exclusively on life sciences. It supports Pharma companies by providing comprehensive end-to-end solutions to improve their performance. Get hassle-free access to all the healthcare and pharma market research reports through our subscription-based platform PharmDelve.